Apollomics Statistics
Total Valuation
Apollomics has a market cap or net worth of $40.24 million. The enterprise value is $40.90 million.
Important Dates
The last earnings date was Monday, December 22, 2025, after market close.
| Earnings Date | Dec 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Apollomics has 2.15 million shares outstanding. The number of shares has increased by 20.11% in one year.
| Current Share Class | 2.15M |
| Shares Outstanding | 2.15M |
| Shares Change (YoY) | +20.11% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 46.15% |
| Owned by Institutions (%) | 4.72% |
| Float | 1.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.08 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.97
| Current Ratio | 0.97 |
| Quick Ratio | 0.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -330.30 |
Financial Efficiency
Return on equity (ROE) is -380.13% and return on invested capital (ROIC) is -150.99%.
| Return on Equity (ROE) | -380.13% |
| Return on Assets (ROA) | -72.29% |
| Return on Invested Capital (ROIC) | -150.99% |
| Return on Capital Employed (ROCE) | -4,084.08% |
| Revenue Per Employee | $533,077 |
| Profits Per Employee | -$2.40M |
| Employee Count | 13 |
| Asset Turnover | 0.30 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Apollomics has paid $260,000 in taxes.
| Income Tax | 260,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +102.56% in the last 52 weeks. The beta is 1.78, so Apollomics's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | +102.56% |
| 50-Day Moving Average | 17.90 |
| 200-Day Moving Average | 10.57 |
| Relative Strength Index (RSI) | 50.25 |
| Average Volume (20 Days) | 23,716 |
Short Selling Information
The latest short interest is 17,568, so 0.82% of the outstanding shares have been sold short.
| Short Interest | 17,568 |
| Short Previous Month | 15,050 |
| Short % of Shares Out | 0.82% |
| Short % of Float | 1.52% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, Apollomics had revenue of $6.93 million and -$31.19 million in losses. Loss per share was -$28.30.
| Revenue | 6.93M |
| Gross Profit | 6.93M |
| Operating Income | -26.42M |
| Pretax Income | -30.93M |
| Net Income | -31.19M |
| EBITDA | -26.36M |
| EBIT | -26.42M |
| Loss Per Share | -$28.30 |
Full Income Statement Balance Sheet
The company has $2.10 million in cash and $744,000 in debt, with a net cash position of $1.36 million or $0.63 per share.
| Cash & Cash Equivalents | 2.10M |
| Total Debt | 744,000 |
| Net Cash | 1.36M |
| Net Cash Per Share | $0.63 |
| Equity (Book Value) | -4.40M |
| Book Value Per Share | -3.99 |
| Working Capital | -343,000 |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -20.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | -20.38M |
| FCF Per Share | -$9.50 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -381.30% |
| Pretax Margin | -446.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Apollomics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.11% |
| Shareholder Yield | -20.11% |
| Earnings Yield | -73.80% |
| FCF Yield | -48.23% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 25, 2024. It was a reverse split with a ratio of 1:100.
| Last Split Date | Nov 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
Apollomics has an Altman Z-Score of -96.62 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -96.62 |
| Piotroski F-Score | 2 |